Benjamin J. Ansell, MD, FACC, FACP, FNLA, received a dual undergraduate degree in biology and music from Cornell University, Ithaca, New York, and his Doctor of Medicine from the University of California Los Angeles (UCLA) School of Medicine, where he subsequently performed an internship and residency in internal medicine. Dr. Ansell currently serves as professor of medicine at the UCLA School of Medicine in the Divisions of General Internal Medicine and Cardiology. He also serves as co-director of the UCLA Cholesterol, Hypertension, & Atherosclerosis Management Program (CHAMP) and director of the UCLA Cardiovascular Discovery Fund.
Dr. Ansell is a fellow of both the American College of Physicians and the American College of Cardiology, a board member of the National Lipid Association, a member of the American Heart Association Council on Arteriosclerosis, Thrombosis, and Vascular Biology, and a diplomate of both the American Board of Internal Medicine and the American Board of Clinical Lipidology. He is also past president of the executive board of the UCLA Department of Medicine.
Chosen by US News and Town & Country magazines as one of the "Best Physicians in America," Dr. Ansell is also a prominent researcher of HDL and its relationship to vascular inflammation and heart disease. He has been principal investigator of the hs-CRP and HDL Effects of Statins Trial (CHEST), the Statins/HDL Increased Function Trial (SHIFT), and the Statin Anti-Rheumatic Activity (SARA) Trial. In addition, he authored or co-authored more than 50 scientific papers and book chapters. He has also been featured by The New York Times, CNN, ABC World News Tonight, 20/20, MSNBC, Dateline NBC, and National Public Radio.
Dr. Ansell serves on the board of directors for Ashford Hospitality Trust (NYSE:AHT). He also is a member of the board of overseers for the Los Angeles Philharmonic Association. Previously from New York state and Colorado, Dr. Ansell has lived in Los Angeles for the last twenty-four years. He is married with three children.